Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) FCF Margin: 2009-2024

Historic FCF Margin for Ani Pharmaceuticals (ANIP) over the last 16 years, with Dec 2024 value amounting to 7.78%.

  • Ani Pharmaceuticals' FCF Margin rose 1149.00% to 16.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 18.83%, marking a year-over-year increase of 501.00%. This contributed to the annual value of 7.78% for FY2024, which is 1484.00% down from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' FCF Margin is 7.78%, which was down 65.61% from 22.61% recorded in FY2023.
  • Ani Pharmaceuticals' 5-year FCF Margin high stood at 22.61% for FY2023, and its period low was -12.67% during FY2022.
  • For the 3-year period, Ani Pharmaceuticals' FCF Margin averaged around 5.91%, with its median value being 7.78% (2024).
  • In the last 5 years, Ani Pharmaceuticals' FCF Margin soared by 3,528bps in 2023 and then plummeted by 1,484bps in 2024.
  • Ani Pharmaceuticals' FCF Margin (Yearly) stood at 4.38% in 2020, then plummeted by 403bps to 0.35% in 2021, then tumbled by 1,302bps to -12.67% in 2022, then surged by 3,528bps to 22.61% in 2023, then crashed by 1,484bps to 7.78% in 2024.